By Phillip Bantz | December 10, 2018
Oler will be primarily responsible for business development, investor relations and legal affairs. He'll be focused on forging relationships with global partners to help advance an Onconova cancer drug called Rigosertib.
By Scott Graham | December 4, 2018
Hearing his first patent case, Brett Kavanaugh says legislators tried and failed to exclude private sales from a list of disqualifying prior art. Other justices sounded less sure.
By Sue Reisinger | December 3, 2018
When Christina Ackermann came onboard in August 2016, Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, was in distress. But she said she knew what she was signing up for: Rebuilding Bausch's governance structure and reshaping her legal department, while helping the business side dig out of a dark financial hole.
By Kristen Rasmussen | November 28, 2018
Ron Honig will oversee all of the legal activities at the Watertown, Massachusetts-based company, which specializes in the development of products to treat serious eye diseases.
The Legal Intelligencer | News
By Max Mitchell | November 26, 2018
A jury from the U.S. District Court for the Eastern District of Pennsylvania on Monday awarded $1.16 million in compensatory damages and $5 million in punitive damages to a plaintiff who said his Israeli manager discriminated against him on the basis of age and American nationality.
By Sue Reisinger | November 12, 2018
David Stark, executive vice president and chief legal officer of financially strapped Teva Pharmaceutical Industries, based in Teva's U.S. headquarters in Parsippany, New Jersey, had to cut his legal staff by 40 percent since 2017 as part of cost-cutting at the Israel-based company. "It was super difficult and hard on morale.” He also plans reductions in outside legal spending.
By Sue Reisinger | November 7, 2018
Tahir Amin, an IP lawyer who is co-founder and co-executive director of Initiatives for Medicines, Access & Knowledge files patent lawsuits against the world's big pharmaceutical companies in an effort to bring down rising drug prices.
By Kristen Rasmussen | November 5, 2018
The pain management and addiction pharmaceutical company announced that James Vollins is taking over as general counsel, chief compliance officer and corporate secretary at the Raleigh, North Carolina-based company.
By Caroline Spiezio | October 17, 2018
Marketing language and the scope of products permitted remain a challenge for cannabis industry GCs in Canada, even after the country's legalization of adult recreational use.
By Kristen Rasmussen | October 11, 2018
Mark Nance is now the chief legal officer and GC at the Phoenix-based company, which is the target of several lawsuits over the the potent opioid medication Subsys.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS